PMID: 1247954Jan 1, 1976Paper

Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities

Cancer
E V Sugarbaker, C M McBride

Abstract

Excision of the primary and isolation-perfusion with 1-phenylalanine mustard was the treatment in 199 patients with invasive Stage I melanoma of the extremities with the goal of improving regional disease control and long-term survival. The determinant survival in patients followed 5-15 years was 83%; Berkson-Gage survivals were 98% at 2 years, 88% at 5 years, and 84% at 10 years. The site of first recurrence was determined in all 49 (25%) patients who failed treatment: three (2%) developed local recurrence, six (3%) developed intransit recurrence, 24 (13%) developed positive regional lymph nodes, 15 (8%) developed systemic metastases, and one developed local recurrence plus positive regional nodes. Of these 49 patients failing treatment, 15 (31%) are currently surviving with no evidence of disease after retreatment of the recurrence. These data are compared to historical controls in the literature. It is concluded that regional control rates are improved by perfusion and that survival has probably been improved. In 14 patients treated by perfusion without local excision, regional control and survival was poor. Single drug (L-PAM) perfusion with the techniques employed is effective in controlling regional subclinical disease, b...Continue Reading

References

Apr 4, 1973·Nature: New Biology·I J Fidler
Feb 1, 1974·Annals of Surgery·J G McCarthyF P Herter
Jan 1, 1968·Scandinavian Journal of Plastic and Reconstructive Surgery·N C Petersen
Dec 1, 1965·Cancer·D B Rochlin, C R Smart
Aug 1, 1966·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·T F Sandeman
Dec 1, 1959·Annals of Surgery·S L GUMPORT, H W MEYER
Aug 1, 1962·American Journal of Surgery·L W GUISS, I MACDONALD
Jul 1, 1962·Archives of Surgery·H W SOUTHWICKF E JOHNSON
Jul 1, 1965·Annals of Surgery·E D MUNDTHJ W RAKER
Sep 1, 1965·American Journal of Surgery·J S STEHLIN, R L CLARK
Sep 1, 1965·American Journal of Surgery·J S STEHLIN, R L CLARK
Jun 1, 1955·Annals of Surgery·W S McCUNE, G S LETTERMAN

❮ Previous
Next ❯

Citations

Nov 1, 1996·Seminars in Surgical Oncology·H R AlexanderD L Bartlett
Apr 1, 1993·Journal of Surgical Oncology·B C VrouenraetsH R Franklin
Jul 30, 1979·World Journal of Surgery·E T KrementzM Campbell
Aug 1, 1987·World Journal of Surgery·H Schraffordt KoopsH Beekhuis
Sep 1, 1989·World Journal of Surgery·F GhussenW Groth
Jan 1, 1984·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·F Ghussen, W Isselhard
Jan 1, 1985·The Japanese Journal of Surgery·I YokoyamaT Kondo
Sep 1, 1984·Canadian Anaesthetists' Society Journal·M E GoldbergF E Rosato
Mar 1, 1985·Annals of Surgery·W F Sindelar
Jan 9, 1998·Acta Anaesthesiologica Scandinavica·I Vrettou, G S Voyagis
Jul 13, 2002·American Journal of Clinical Dermatology·Pearon G Lang
Jan 1, 1977·The Journal of Dermatologic Surgery and Oncology·A W KopfR S Rodriguez-sains
Jan 1, 1985·Cancer Investigation·J H MuchmoreE T Krementz
Jan 1, 1985·Critical Reviews in Oncology/hematology·M Markman
Sep 2, 1998·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R J KlicksB B Kroon
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B B KroonJ A van Dongen
Oct 1, 1989·European Journal of Cancer & Clinical Oncology·Z H SiddikA W Boddie
Jan 1, 1993·Cancer Treatment Reviews·L Hafström, J Mattsson
Jul 1, 1984·Disease-a-month : DM·M Markman
Sep 1, 1983·Clinical Immunology and Immunopathology·M G BernengoG Zina
Jan 1, 1989·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·F BelliN Cascinelli
May 1, 1981·Clinical Immunology and Immunopathology·P G NataliS Ferrone
Jun 1, 1979·Cancer Treatment Reviews·J TonakH Groitl
Aug 1, 1985·The British Journal of Surgery·M GutmanR R Rozin
Jan 1, 1988·The British Journal of Surgery·J H Shaw, J B Koea
May 1, 1984·Journal of Surgical Oncology·W P FontijneC R Wildevuur
Jun 1, 1980·Cancer Treatment Reviews·Y T Lee
Mar 1, 1982·Cancer·C P KarakousisJ H Ewing

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.